Tubulointerstitial Nephritis and Uveitis Syndrome

Guerriero, Silvana; Vischi, Antonio; Giancipoli, Giovanni; Leozappa, Marco; Ferrari, Tommaso Micelli
July 2006
Journal of Pediatric Ophthalmology & Strabismus;Jul/Aug2006, Vol. 43 Issue 4, p241
Academic Journal
Tubulointerstitial nephritis and uveitis syndrome is likely underdiagnosed. A 13-year-old girl with no significant medical history had photophobia, ocular pain, and decreased visual acuity. Bilateral papilledema was present. Renal biopsy revealed interstitial nephritis. Immunosuppressive therapy was added (3 mg/kg/d of cyclosporine). One year later, visual acuity was 20/20 and findings were normal on ocular examination and laboratory tests.


Related Articles

  • Uveitis survey in children. I H Hamade // British Journal of Ophthalmology;May2009, Vol. 93 Issue 5, p569 

    BACKGROUND/AIMS: This is a retrospective cohort uveitis survey to determine the clinical features of uveitis in children and assess the rate of complications at two referral centres in Saudi Arabia. METHODS: All children under the age of 16 years presenting with uveitis for the first time...

  • Tubulointerstitial nephritis and uveitis syndrome in a mother and her son. Dusek, Jiri; Urbanova, Ivana; Stejskal, Josef; Seeman, Tomas; Vondrak, Karel; Janda, Jan // Pediatric Nephrology;Nov2008, Vol. 23 Issue 11, p2091 

    A mother and her son, both with tubulointerstitial nephritis and uveitis syndrome (TINU) are reported. The nephritis presented itself at 13 years in the mother and at 10 years in her son. Glomerular filtration (GFR) decreased in both, and renal biopsies confirmed the diagnosis. Nephritis...

  • Implant benefits non-infectious posterior segment uveitis. Charters, Lynda // Ophthalmology Times;11/15/2004, Vol. 29 Issue 22, p34 

    This article reports that intraocular implantation of fluocinolone acetonide has resulted in significant decreases in the recurrence rate of non-infectious posterior segment uveitis and improvements in visual acuity (VA). This was announced at the annual meeting of the Retina Society in...

  • Clinical background comparison of patients with and without ocular inflammatory attacks after initiation of infliximab therapy. Yoshida, Atsushi; Kaburaki, Toshikatsu; Okinaga, Kimiko; Takamoto, Mitsuko; Kawashima, Hidetoshi; Fujino, Yujiro // Japanese Journal of Ophthalmology;Nov2012, Vol. 56 Issue 6, p536 

    Purpose: To examine the factors affecting the efficacy of infliximab (IFX) as a treatment for uveitis in Behçet's disease. Methods: Clinical records of 29 patients with refractory uveoretinitis were examined retrospectively for the period between 6 months before the initiation of IFX therapy...

  • Implant is new approach to uveitis. Charters, Lynda; Whitcup, Scott M. // Ophthalmology Times;2/1/2010, Vol. 35 Issue 3, p20 

    The article reports on the single sustained-release dexamethasone intravitreal implant for patients with intermediate or posterior uveitis. It notes that practitioner Scott M. Whitcup has said that the implant provides a resolution of inflammation and improvement in visual acuity (VA) He adds...

  • Validity of using vision-related quality of life as a treatment end point in intermediate and posterior uveitis. Murphy, Conor C.; Greiner, Kathrin; Piskova, Jarka; Frost, N. Andrew; Forrester, John V.; Dick, Andrew D. // British Journal of Ophthalmology;Feb2007, Vol. 91 Issue 2, p154 

    Aim: To evaluate the responsiveness of the Vision core module 1 (VCM1) vision-related quality of life (VR-QOL) questionnaire to changes in visual acuity in patients with posterior and intermediate uveitis and to validate its use as a clinical end point in uveitis. Methods: Logarithm of the...

  • Uveitis in Adult Patients with Poststreptococcal Reactive Arthritis: the First Two Cases Reported associated with Uveitis. Kobayashi, S.; Tamura, N.; Ikeda, M.; Sakuraba, K.; Matsumoto, T.; Hashimoto, H. // Clinical Rheumatology;Nov2002, Vol. 21 Issue 6, p533 

    : We describe two adult patients with poststreptococcal reactive arthritis (PSRA), both of whom concomitantly developed uveitis. These are the first two cases reported. Because uveitis may result in permanent damage to visual acuity, this complication should be widely recognised in patients with...

  • Safety and efficacy of infliximab therapy in active behcet’s uveitis: an open-label trial. Al-Rayes, H.; Al-Swailem, R.; Al-Balawi, M.; Al-Dohayan, N.; Al-Zaidi, S.; Tariq, M. // Rheumatology International;Nov2008, Vol. 29 Issue 1, p53 

    In this open-label trial, ten male patients with active Behcet’s uveitis were enrolled. Initially, two infliximab infusions (5 mg/kg) were given at weeks 0 and 2. The patients continued to receive conventional therapy on recurrence of severe uveitis (RSU) attack. The patients with further...

  • PRACTICE: WHAT IS YOUR CALL? Headache, red eyes, blurred vision and hearing loss. Chan, Errol Wei'en; Sanjay, Srinivasan; Chang, Benjamin Chong Ming // CMAJ: Canadian Medical Association Journal;8/10/2010, Vol. 182 Issue 11, p1205 

    The article evaluates a case wherein a 48-year-old Chinese woman is presented with a history of redness, blurred vision in both eye and had a headache and hearing loss in both ears. It analyses the occurrence of uveomeningeal syndrome in the patient due to her clinical features of lymphocytic...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics